VANCOUVER, British Columbia--(BUSINESS WIRE)--April 4, 2006--MIV Therapeutics (OTCBB:MIVT - News; FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, has appointed nationally recognized Wall Street medical device analyst and industry authority Mark Landy as President of the Company.
